Other functions, other genes: Alternative activation of antigen- presenting cells

Immunity

Volumn 10, Issue 2, 1999, Pages 137-142

  Goerdt, Sergij ^a   Orfanos, Constantin E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4;

ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL DIFFERENTIATION; DENDRITIC CELL; DOWN REGULATION; GENE FUNCTION; GRANULOMA; HELPER CELL; INFLAMMATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REVIEW;

EID: 0033082935     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80014-X     Document Type: Review

References (47)

1. Adema, G.J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., et al. (1997). A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387, 713-717.
2. Baadsgaard, O., Fox, D.A., and Cooper, K.D. (1988). Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes. J. Immunol. 140, 1738- 1744.
3. Becker, S., and Daniel, E.G. (1990). Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: Effects on Fc receptors HLA-D antigens, and superoxide production. Cell. Immunol. 129, 351-362.
4. Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., and Granstein, R.D. (1995). IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154, 1280-1286.
5. Bonder, C.S., Dickensheets, H.L., Finlay-Jones, J.J., Donnelly, R.P., and Hart, P.H. (1998). Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J. Immunol. 160, 4048-4056.
6. Calandra, T., Bernhagen, J., Metz, C.N., Spiegel, L.A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71.
7. Chang, Z.-L., Bonvini, E., Varesio, L., Holden, H.T., and Herberman, R.B. (1988). Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin. Cell. Immunol. 114, 282-292.
8. Chang, M.-D.Y., Pollard, J.W., Khalili, H., Goyert, S.M., and Diamond, B. (1993). Mouse placental macrophages have a decreased ability to present antigen. Proc. Natl. Acad. Sci. USA 90, 462-466.
9. Cheung, D.L., Hart, P.H., Vitti, G.F., Whitty, G.A., and Hamilton, J.A. (1990). Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunol. 71, 70-75.
10. Clare-Salzler, M.J., Brooks, J., Chai, A., Van Herle, K., and Anderson, C. (1992). Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J. Clin. Invest. 90, 741-748.
11. Cua, D.J., and Stohlman, S.A. (1997). In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J. Immunol. 159, 5834-5840.
12. Dai, R., and Streilein, J.W. (1997). Ultraviolet B-exposed and soluble factor-pre-incubated epidermal Langerhans cells fail to induce contact hypersensitivity and promote DNP-specific tolerance. J. Invest. Dermatol. 108, 721-726.
13. Desvignes, C., Bour, H., Nicolas, J.-F., and Kaiserlian, D. (1996). Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur. J. Immunol. 26, 1756-1761.
14. Djemadji-Oudjiel, N., Goerdt, S., Kodelja, V., Schmuth, M., and OrFanos, C.E. (1996). Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1+/-, 25F9-) in psoriatic dermis. Arch. Dermatol. Res. 288, 757-764.
15. Enk, A.H., Angeloni, V.L., Udey, M.C., and Katz, S.I. (1993). Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151, 2390-2398.
16. Fadok, V.A., Bratton, D.L., Konowal, A., Freed, P.W., Westcott, J.Y., and Henson, P.M. (1998). Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890-898.
17. Fenton, M.J., Buras, J.A., and Donnelly, R.P. (1992). IL-4 reciprocally regulated IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149, 1283-1288.
18. Geng, Y.-j., and Hansson, G.K. (1992). Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89, 1322-1330.
19. Goerdt, S., Walsh, L.J., Murphy, G.F., and Pober, J.S. (1991). Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J. Cell Biol. 113, 1425-1437.
20. Goerdt, S., Bhardwaj, R., and Sorg, C. (1993a). Inducible expression of MS-1 high-molecular weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am. J. Pathol. 142, 1409-1422.
21. Goerdt, S., Kolde, G., Bonsmann, G., Hamann, K., Czarnetzki, B., Andreesen, R., Luger, T., and Sorg, C. (1993b). Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: Diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J. Pathol. 170, 421-427.
22. Holt, P.G., Schon-Hegard, M.A., and Oliver, J. (1988). MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage population. J. Exp. Med. 167, 262-274.
23. Högger, P., Dreier, J., Droste, A., Buck, F., and Sorg, C. (1998). Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161,1883-1890.
24. Kirschmann, D.A., He, X., and Murasko, D.M. (1994). Inhibition of macrophage-induced antigen-specific T-cell proliferation by polyl:C role of suppressor macrophages. Immunology 82, 238-243.
25. Knop, J., Taborski, B., and de Maeyer-Guignard, J. (1987). Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J. Immunol. 136, 3684-3687.
26. Kodelja, V., Müller, C., Tenorio, S., Schebesch, C., Orfanos, C.E., and Goerdt, S. (1997). Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197, 478-493.
27. Kodelja, V., Müller, C., Politz, O., Hakij, N., Orfanos, C.E., and Goerdt, S. (1998). Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J. Immunol. 160, 1411-1418.
28. Laing, I.A., Goldblatt, J., Eber, E., Hayden, C.M., Rye, P.J., Gibson, N.A., Palmer, L.J., Burton, P.R., and Le Souef, P.N. (1998). A polymorphism of the CC16 gene is associated with an increased risk of asthma. J. Med. Genet. 35, 463-467.
29. Mosser, D.M., and Handman, E. (1992). Treatment of murine macrophages with interferon-gamma inhibits their ability to bind leishmania promastigotes. J. Leukocyte Biol. 52, 369-376.
30. Mues, B., Langer, D., Zwadlo, G., and Sorg, C. (1989). Phenotypic characterization of macrophages in human term placenta. Immunology 67, 303-307.
31. Munder, M., Eichmann, K., and Modolell, M. (1998). Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160, 5347-5354.
32. Nakamura, M., Xavier, R.M., Tsunematsu, T., and Tanigawa, Y. (1995). Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor. Proc. Natl. Acad. Sci. USA 92, 9463-9467.
33. Oehler, J.R., Herberman, R.B., Campbell, D.A., Jr., and Djeu, J.Y. (1977). Inhibition of rat mixed lymphocyte cultures by suppressor macrophages. Cell. Immunol. 29, 238-250.
34. Saha, B., Das, G., Vohra, H., Ganguly, N.K., and Mishra, G.C. (1994). Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur. J. Immunol. 24, 2618-2624.
35. Schebesch, C., Kodelja, V., Müller, C., Hakij, N., Orfanos, C.E., and Goerdt, S. (1997). Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 92, 478-486.
36. Schmidt Pak, A., Ip, G., Wright, M.A., and Young, M.R.I. (1995). Treating tumor-bearing mice with low-dose γ-interferon plus tumor necrosis factor-α to diminish immune suppressive granulocytemacrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy. Cancer Res. 55, 885-890.
37. Simon, J.C., Cruz, P.D.J., Bergstresser, P.R., and Tigelaar, R.E. (1990). Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. J. Immunol. 145, 2087-2091.
38. Stadecker, M.J., and Villanueva, P.O.F. (1994). Accessory cell signals regulate Th-cell responses: From basic immunology to a model of helminthic disease. Immunol. Today 15, 571-574.
39. Standiford, T.J., Kunkel, S.L., Liebler, J.M., Burdick, M.D., Gilbert, A.R., and Strieter, R.M. (1993). Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 9, 192-198.
40. Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologie macrophage activation. J. Exp. Med. 176, 287-292.
41. Steinbrink, K., Sorg, C., and Macher, E. (1996). Low zone tolerance to contact allergens in mice: A functional role for CD8+ T helper type 2 cells. J. Exp. Med. 183, 759-768.
42. Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., and Enk, A.H. (1997). Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159, 4772-4780.
43. Stevens, S.R., Shibaki, A., Meunier, L., and Cooper, K.D. (1995). Suppressor T cell-activating macrophages in ultraviolet-irradiated human skin induce a novel, TGG-beta dependent form of T cell activation characterized by deficient IL-2r alpha. J. Immunol. 155, 5601-5607.
44. Szekanecz, Z., Haines, G.K., Lin, T.R., Harlow, L.A., Goerdt, S., Rayan, G., and Koch, A.E. (1994). Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 37, 221-231.
45. Villanueva, P.O.F., Harris, T.S., Ricklan, D.E., and Stadecker, M.J. (1994). Macrophages from schistomal egg granulomas induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J. Immunol. 152, 1847-1855.
46. Walsh, L.J., Goerdt, S., Pober, J.S., Sueki, H., and Murphy, G.F. (1991). MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells. Lab. Invest. 65, 732-741.
47. Wilckens, T., and De Rijk, R. (1997). Glucocorticoids and immune function: Unknown dimensions and new frontiers. Immunol. Today 18, 418-424.